🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: SC group

Found 0 matching trials

Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants

PHASE1

This is a Phase 1 study with 2 parallel groups of healthy participants. Par...

Status

Active Not Recruiting

Location

Clinical Pharmacology of Miami- Site Number : 8400001

Start Date

2026-06-11

Trial ID

NCT07646548

Treatments Being Tested

Dupilumab coformulated with berahyaluronidase alfa Dupilumab

A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

PHASE1

Phase 1 randomized, open-label, multicenter, parallel-group study designed ...

Status

Completed

Location

Yeungnam University Hospital

Start Date

2016-09-29

Trial ID

NCT02883452

Treatments Being Tested

CT-P13 CT-P13 CT-P13 CT-P13 CT-P13 CT-P13

Study to Access the Relative Bioavailability of Subcutaneous Dose of Nemolizumab When Administered Via Auto-Injector Versus Dual-Chamber Syringe

PHASE1

This study was to compare the rate and extent of absorption of a single dos...

Status

Completed

Location

Galderma Investigational Site 7024

Start Date

2022-08-11

Trial ID

NCT05405985

Treatments Being Tested

Nemolizumab Nemolizumab

A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

PHASE3

This randomized, double-blind, parallel group study compares the efficacy a...

Status

Completed

Location

Multiple Locations

Start Date

2010-09

Trial ID

NCT01194414

Treatments Being Tested

tocilizumab SC tocilizumab IV placebo to tocilizumab SC placebo to tocilizumab IV Disease-modifying antirheumatic drugs (DMARDs)

Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation

PHASE3

This OLE part is an optional, single arm, multicenter, open-label extension...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2027-12-30

Trial ID

NCT07739888

Treatments Being Tested

Abelacimab

A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

PHASE1

The objective of this study is to compare the pharmacokinetic and pharmacod...

Status

Completed

Location

Multiple Locations

Start Date

2008-03

Trial ID

NCT00653822

Treatments Being Tested

alefacept placebo

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia

PHASE2

Primary Objective: To evaluate the effect of alirocumab (SAR236553/REGN727...

Status

Completed

Location

Investigational Site Number 840616

Start Date

2011-01

Trial ID

NCT01288469

Treatments Being Tested

Alirocumab Placebo (for alirocumab)Atorvastatin Placebo (for atorvastatin)

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

PHASE2

This study is evaluating the safety and immunogenicity of GSK Biologicals' ...

Status

Completed

Location

GSK Investigational Site

Start Date

2004-08-01

Trial ID

NCT00129129

Treatments Being Tested

GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine ActHIB Pediarix Prevnar Menomune

Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient

N/A

Sickle cell disease is characterized by chronic hemolytic anemia, painful c...

Status

Completed

Location

Chu de La Guadeloupe

Start Date

2020-10-14

Trial ID

NCT06986837

rTMS as a Treatment of Visceral Pain Secondary to Malignancy

The purpose of this study is to assess the efficacy of rTMS over primary mo...

Status

Completed

Location

Multiple Locations

Start Date

2010-01

Trial ID

NCT02092805

Treatments Being Tested

Real rTMS(20 Hz, 10 trains, inter train interval 30 sc with total pulses 2000, intensity 80% of motor threshold) daily for 10 consecutive days (5 days/week)Sham rTMS (same parameters but with coil elevated and angled away from the head) every day for 10 consecutive days (5 days/week).

Previous Next